Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial

Gelijkaardige items

• Glucagon like peptide 1 analogue, Liraglutide, reduces adipose insulin resistance and hepatic de novo lipogenesis in Nonalcoholic Steatohepatitis: Sub-study results of a phase II randomised-control clinical trial
  door: Armstrong, M, et al.
  Gepubliceerd in: (2013)
• Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.
  door: Armstrong, M, et al.
  Gepubliceerd in: (2015)
• Subcutaneous adipose tissue insulin resistance and lipolysis in patients with nonalcoholic steatohepatitis
  door: Armstrong, M, et al.
  Gepubliceerd in: (2013)
• Liraglutide for patients with non-alcoholic steatohepatitis.
  door: Dale, A, et al.
  Gepubliceerd in: (2016)
• Orlistat for overweight subjects with nonalcoholic steatohepatitis.
  door: Dowman, J, et al.
  Gepubliceerd in: (2009)